EX-2.1
from 8-K
92 pages
Agreement and Plan of Merger by and Among Apex Bioventures Acquisition Corporation Apex Acquisition Sub, Inc., Dynogen Pharmaceuticals, Inc., and Kate Bingham and Michael Bigham, Acting Jointly as the Holder Representatives Dated as of February 5, 2008
12/34/56
